Monitoring
Women should be evaluated every 3 months for treatment response and development of any adverse effects. Once stable, monitoring is every 6 months.
Combination therapy may be required to achieve results in ameliorating hyperandrogenism.
Long growth cycle of hair follicles mandates that treatments directed against hirsutism not be abandoned prematurely. Medical therapy against hirsutism should be given for at least 6 months before deciding on efficacy.[12][78]
Women undergoing hormonal infertility treatment (letrozole, clomiphene, gonadotropins, assisted reproductive technologies) will require frequent follow-up.
As a fertility treatment, metformin is given long term.
Use of this content is subject to our disclaimer